---
title: "Key facts: Bayer Opposes $7.25B Roundup Transfer; Farm Bill Threatens"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/288520479.md"
description: "Bayer opposes transferring the $7.25B Roundup class action from Missouri to California, causing a 5% share drop. Additionally, legislative changes like the House Farm Bill threaten to remove legal shields for pesticide makers, impacting Bayer AG."
datetime: "2026-06-03T05:13:45.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/288520479.md)
  - [en](https://longbridge.com/en/news/288520479.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/288520479.md)
generator: "portal-rs"
---

# Key facts: Bayer Opposes $7.25B Roundup Transfer; Farm Bill Threatens

-   Bayer will oppose a bid to move the $7.25B Missouri Roundup class action to California federal court, arguing the case belongs in Missouri state court; shares fell about 5% after the transfer motion. 1 2
-   Legislative moves affect Bayer AG (BAYN): some state bills limiting pesticide suits had mixed success; House Farm Bill would strip a legal shield for pesticide makers; Senate action pending. 3

### Related Stocks

- [BAYRY.US](https://longbridge.com/en/quote/BAYRY.US.md)
- [BAYN.DE](https://longbridge.com/en/quote/BAYN.DE.md)
- [BAYZF.US](https://longbridge.com/en/quote/BAYZF.US.md)

## Related News & Research

- [Bayer says Japan approves sevabertinib for HER2-mutant NSCLC](https://longbridge.com/en/news/296745277.md)
- [Bayer Swings to Net Profit on Smaller Litigation Charges](https://longbridge.com/en/news/294778020.md)
- [Deere Earnings: Has the Stock Outrun the Farm Cycle?](https://longbridge.com/en/news/296784264.md)
- [Suedzucker updates SBTi climate targets, adds agriculture emissions cuts through 2030/31](https://longbridge.com/en/news/297002305.md)
- [Neogenyx Fuels, Adams Land & Cattle break ground on agricultural renewable natural gas facility in Nebraska](https://longbridge.com/en/news/296895159.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**